For most recent publications, please see Google Scholar and PubMed.​

​​

Highlighted Publications

​

A Bagha, A Helmi, A Jaberi, G Hirschfield, K Leung. Improvement in Irretractable Pruritus with Intrahepatic Portosystemic Shunt Embolization: From MAID to a New Lease on Life. Case Reports Hepatol. 2026 Feb 18; 2026:5822560. doi: 10.1155/crhe/5822560.

​

KK Leung, W Li, B Hansen, A Gulamhusein, L Lapointe-Shaw, A Ricciuto, EI Benchimol, J Flemming, GM Hirschfield. Understanding hepatopancreatobiliary cancer risks in a population-based primary sclerosing cholangitis-inflammatory bowel  disease cohort. Hepatology, 2026 Feb 4. Online ahead of print. doi: 10.1097/HEP.0000000000001692.

​​

N Tan, K Leung. PSC as an Independent Risk Factor for CRC Without IBD: Can Observed Epidemiological

Trends Help Uncover Biological Mechanisms and Guide Surveillance Strategies? Alimentary Pharmacology &

Therapeutics (2025): 1–2, https://doi.org/10.1111/apt.70325.

​

KK Leung, M Youssef, Y Xiao, C Streutker, A Gulamhusein, B Hansen, N Calo, G May, J Mosko, G Hirschfield. Endoscopic Retrograde Cholangiopancreatography & Primary Sclerosing Cholangitis: A Retrospective Study of a High-Volume Programme. Journal of the Canadian Association of Gastroenterology, 2025; gwaf018, doi:10.1093/jcag/gwaf018.

​

M Deeb, KK Leung, R Ward, JJ Feld, KHM Kuo, GM Hirschfield. Hepatobiliary disease and outcomes for

patients with sickle cell disease: a 30-year review of 1009 patients. Hepatology Communications 9(5):e0712, May1

2025.

 

KK Leung, W Li, B Hansen, A Gulamhusein, L Lapointe-Shaw, AA Shaheen, A Ricciuto, EI Benchimol, J Flemming, GM Hirschfield. Primary Sclerosing Cholangitis-Inflammatory Bowel Disease: Epidemiology, Mortality, and Impact of Diagnostic Sequence. JHEP Reports, Volume 7, Issue 3, March 2025, 101272.

 

KK Leung, GM Hirschfield. Autoimmune Hepatitis and Overlap Syndromes. Book chapter in: Cross, T. 5eds) Liver Disease in Clinical Practice (2nd edition). In Clinical Practice Series. Springer, Cham. November 2022. https://doi.org/10.1007/978-3-031-10012-3_10. (Chapter 10, pages 195-222).

 

KK Leung, GM Hirschfield. Autoantibodies in Primary Biliary Cholangitis. Review article in special edition in: Clin Liver Dis, 2022 Nov;26(4):613-627. doi: 10.1016/j.cld.2022.06.004.

 

KK Leung, GM Hirschfield. Elevated Serum Aminotransferases. JAMA Diagnostic Test Interpretation section. JAMA. 2022 Feb 8;327(6):580-581. doi: 10.1001/jama.2022.0255.

 

KK Leung, A Kim, BE Hansen, L Lilly, N Selzner, K Patel, M Bhat, GM Hirschfield, Z Galvin. The impact of primary liver disease and social determinants on outcomes in patients waitlisted for liver transplant– a single centre review. Liver Transpl. 2021 Dec;27(12):1733-1746. doi: 10.1002/lt.26195. Epub 2021 Sep 21.

 

KK Leung, M Deeb, A Gulamhusein. Recurrent Primary Sclerosing Cholangitis: Current Understanding, Management, and Future Directions. Semin Liver Dis 2021; 41(03): 409-420. doi: 10.1055/s-0041-1730950.

 

KK Leung, PD James, A Jaberi, G Hirschfield. Esophageal Stenting as Bridge Therapy to Direct Intrahepatic Portocaval Shunt for Refractory Variceal Bleeding. Hepatology. 2021 Apr;73(4):1618-1620. doi: 10.1002/hep.31519.

 

KK Leung, M Deeb, G Hirschfield. Review Article: Pathophysiology and Management of Primary Biliary Cholangitis. Aliment Pharmacol Ther. 2020 Oct;52(7):1150-1164. doi: 10.1111/apt.16023.

​

K Leung, V Huang. Editorial: Pregnancy and the Gastroenterologist. Aliment Pharmacol Ther. 2020 Sep;52(5):877-878. doi: 10.1111/apt.15977.

​

Collaborations

​

G Cancado, B Chen, M Cameron, I Houri, K Leung, A Gulamhusein, B Hansen, G Hirschfield. High biochemical

remission rates inpatients with primary biliary cholangitis treated with ‘triple’ anti-cholestatic therapy. Hepatology

Communications 2025 Sep 29;9(10):e0798. doi: 10.1097/HC9.0000000000000798.
 

C Tsien, H Tan, S Sharma, N Palaniyappan, P Wijayasiri, K Leung, et al. Long-term outcomes of liver transplant

recipients followed up in non-transplant centres: Care closer to home. Clin Med (Lond). 2021 Jan;21(1):e32-e38.

doi: 10.7861/clinmed.2020-0609.

​